Articles of Interest

Home Archive "Articles of Interest"
DEA and HHS joint letter on Medications for Opioid Use Disorder (MOUD)
Articles of Interest Legislative/Regulatory

DEA and HHS joint letter on Medications for Opioid Use Disorder (MOUD)

DEA’s Diversion Control Division is pleased to post this joint letter from DEA and HHS supporting the expansion of Medications for Opioid Use Disorder (MOUD). DEA and HHS support the expansion of MOUD especially in rural or underserved areas. DEA is asking its registrants to ensure an adequate and uninterrupted supply of MOUD products when appropriately prescribed and asks...
xylezine
Articles of Interest Public Resources

Crisis in East Tennessee: The Alarming Surge of Tranquilizer-Related Deaths

Greetings from the Tennessee Society of Addiction Medicine, where we are deeply committed to addressing the critical issues surrounding addiction within our state. In this article by Vinay Simlot, which can be found here in its original format and context, we explore a pressing concern that has recently come to light, as reported by WBIR: the tragic rise in tranquilizer-related deaths...
Mitigating risks from human Xylazine exposure
Articles of Interest Education

Mitigating Risks from Human Xylazine Exposure

This document offers a comprehensive overview of a vital meeting titled “Mitigating Risks from Human Xylazine Exposure.” Hosted by the Reagan-Udall Foundation for the FDA, the meeting features expert speakers from prestigious organizations, including the White House Office of National Drug Control Policy and the U.S. Food and Drug Administration. The meeting’s agenda...
Congratulations to Dr. Daniel Sumrok for Board Position A.S.A.M. Region X
Articles of Interest

Congratulations to Dr. Sumrok- Region X Board Member

Congratulations to Dr. Daniel Sumrok, M.D., FAAFP, DFASAM, on his appointment as ASAM’s Region X Board Member. This prestigious position is a testament to his unwavering commitment to the field of Addiction Medicine and his remarkable contributions to the community. In this article, we will delve into the significance of Dr. Sumrok’s role and his dedication to advancing...
Addiction Medicine Updates Articles of Interest

Tennessee Society of Addiction Medicine (TNSAM) Statement on Workplace Safety in Medical Practices

TNSAM represents addiction medicine physicians dedicated to providing the best medical care to patients afflicted with substance use disorders. We recognize that high-quality care can only be achieved in an environment where healthcare workers feel secure and protected. Recent reports and discussions highlight an urgent need to address workplace safety concerns affecting healthcare...
Articles of Interest Legislative/Regulatory

TMA Day on the Hill

The Tennessee Society of Addiction Medicine Participated in the Tennessee Medical Association Day on the Hill Event Nashville, TN -March 7, 2023 The Tennessee Society of Addiction Medicine (TNSAM) proudly took part in TMA’s prestigious annual policy briefing and lobby day in Nashville, leaving an indelible mark on the landscape of addiction medicine. This highly...
HB309-SB1072--Decriminalization-of-Marijuana
Addiction Medicine Updates Articles of Interest Legislative/Regulatory Public Resources

HB309/SB1072 Decriminalization of Marijuana

February 27, 2023 The Honorable Clay Doggett Chair House Subcommittee on Criminal Justice 1st Floor, State Capitol 600 Dr. Martin L. King, Jr. Blvd. Nashville, TN 37243 Re: TNSAM’s Support for HB309/SB1072 Dear Chair Doggett, On behalf of the Tennessee Society of Addiction Medicine (TNSAM), the medical specialty society representing physicians and clinicians in Tennessee who specialize in the...
DEA-Extends-Telemedicine-Flexibilites-Adopted-During-the-Covid-19-PHE-with-Appropriate-Safeguards
Addiction Medicine Updates Articles of Interest Legislative/Regulatory

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The...
Articles of Interest Legislative/Regulatory

DEA Announces Important Change to Registration Requirement

Dear DEA Registrant: On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA-Waiver Program.” DEA fully supports this significant policy reform. At this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing everything in...
doctor-in-science-laboratory-analyzing-tray-of-vac-2021-09-04-03-06-45-utc
Articles of Interest Legislative/Regulatory

Toxicology Question of the Week: Approaches for Harm Reduction in the State of Tennessee

January 20, 2023: Approaches for Harm Reduction in the State of Tennessee TOXICOLOGY QUESTION OF THE WEEK JANUARY 20, 2023 APPROACHES FOR HARM REDUCTION IN THE STATE OF TENNESSEE As promised, the following are the thoughts/proposals of Dr. Reid Finlayson. I support harm reduction but propose that reorganization to improve evaluation and evidence-based medical treatment will resolve...